Capsaicin

SKU: orb1309898

Description

Capsaicin, the pungent component of chili peppers, is a potent TRPV1 channel agonist (EC50 = 0.29 µM). This research tool is widely used to study pain, inflammation, and itch in vivo, and to investigate its antitumor, antioxidant, and neurobiological effects in cellular models.

Research Area

Cell Biology, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 404-86-4
• MW: 305.41
• Purity: 99.88%
• Formula: C₁₈H₂₇NO₃
• SMILES: C(NC(CCCC/C=C/C(C)C)=O)C1=CC(OC)=C(O)C=C1
• Target: Autophagy,TRP/TRPV Channel,Apoptosis
• Solubility: 10% DMSO+90% Saline:1.53 mg/mL (5.01 mM);DMSO:260 mg/mL (851.31 mM)

Bioactivity

• Target IC50:
  A2058 cells:> 100 μM|FaDu cells:150 µM|MCF-7 cells:49.97 μM|T47D cells:100 μM|TRPV1 (HEK293 cells):0.29 μM (EC50)|HEK293 cells:0.008 μM|BGC-823 cells:4.659 μM|K562 cells:49.41 μM|SK-MEL-2 cells:> 100 μM|HCT116 cells:40.16 μM|SKOV3 cells:22.03 μM|B16 F10 cells:> 100 μM|MDA-MB-231 cells:120 μM|HeLa cells:> 50 μM|NCI-H4 cells:30.66 μM
• In Vivo:
  METHODS: To investigat the effects on thermoregulation and locomotor activity, Capsaicin (10-20 mg/kg, saline+3% ethanol+10% Tween 80) was administered by Single gavage to C57BL/6J mice with WT and TRPV1 KO. Results: Oral administration of capsaicin resulted in a long-term increase in TRPV1-dependent acute hypothermia and TRPV1-independent locomotor activity, in addition to activation of brain circuits controlling thermoregulation and metabolism. METHODS: To assay neur Protective activity, Capsaicin (5-20 mg/kg) was administered orally to mice given scopolamine once daily for seven days. Results: Capsaicin exerted empirical neur Protective effects through restoration of mitochondrial function, antioxidant effects and modulation of pro-inflammatory cytokines. A 10 mg/kg dose of Capsaicin for seven consecutive days wa the most effective dose.
• In Vitro:
  METHODS: Human pharyngeal squamous carcinoma cells FaDu were treated with Capsaicin (50-300 µM) for 24-72 h. Cell viability was assayed using MTT Assay. Results: A the dose of Capsaicin increased, a decrease in enhanced cell growth was shown. Percentage of viable cells decreased with increase in incubation time the IC50 value was about 150 µM. METHODS: Human oral epidermoid carcinoma cells KB were treated with Capsaicin (150-250 µM) for 24-48 h. Apoptosis was detected using Hoechst staining. Results: Capsaicin induced apoptosis in KB cells.
• Cell Research:
  Capsaicin is dissolved in DMSO and stored, and then diluted with appropriate medium before us. FaDu cells are plated at a density of × 0^5 cells/well on 24-well plate. After overnight growth the cells are treated with various concentration of Capsaicin (0 μM, 50 μM, 100 μM, 50 μM, 200 μM, 50 μM, 300 μM, and 50 μM) for 24, 48 and 72 hours, with medium replacement every 24 hours. A the end of treatment, 30 μL o the tetrazolium compound MTT, and 270 μl of fresh medium are added. After further incubation for 4 hours at 37℃, 200 μL of 0.1 N HCl in 10% SDS is added into Each well to dissolve the tetrazolium crystals. Finally the absorbance at a wavelength of 540 nM is recorded using an ELISA plate reade.

Storage & Handling

• Storage: keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Capsaicin, Autophagy, Apoptosis, 8-Methyl-N-vanillyl-trans-6-nonenamide, (E)-Capsaicin, hTRPV1( in HEK293 cell), Qutenza, Zostrix, TRPVChannel, TRPV Channel, TRP Channel, TRPChannel

Compound Identifiers

PubChem CID

1548943